Jonas Andreas Schmid
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Molecular Biology top 10%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
Papers in
- Oncology 9
- PARP inhibition in cancer therapy 5
- Cytokine Signaling Pathways and Interactions 2
- Cancer-related Molecular Pathways 2
-
- DNA Repair Mechanisms 9
- CRISPR and Genetic Engineering 4
- Co-authors
- Massimo Lopes (6 shared papers)Matteo Berti (3 shared papers)Ralph Zellweger (3 shared papers)Raquel Herrador (3 shared papers)Alessandro Vindigni (1 shared paper)Damian Dalcher (1 shared paper)Karun Mutreja (1 shared paper)Jana Krietsch (6 shared papers)
- Journals
- Molecular Cell (3 papers)Cancer Cell (2 papers)Nature Communications (2 papers)The Journal of Cell Biology (1 paper)Chemical Communications (1 paper)
- Partner nations
- SwitzerlandUnited StatesNetherlands
In The Last Decade
Jonas Andreas Schmid
17 papers receiving 1.6k citations
Jonas Andreas Schmid's Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 749
- Molecular Biology 1.3k
- Immunology 231
- Cancer Research 152
- Cell Biology 110
Countries citing papers authored by Jonas Andreas Schmid
This map shows the geographic impact of Jonas Andreas Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Andreas Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Andreas Schmid more than expected).
Fields of papers citing papers by Jonas Andreas Schmid
This network shows the impact of papers produced by Jonas Andreas Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Andreas Schmid. The network helps show where Jonas Andreas Schmid may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonas Andreas Schmid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells Hit paper breakdown → | 2015 | 542 |
| 2 | 2018 | 301 | |
| 3 | 2017 | 192 | |
| 4 | 1985 | 177 | |
| 5 | 2018 | 84 | |
| 6 | 1982 | 79 | |
| 7 | 2020 | 75 | |
| 8 | 2023 | 47 | |
| 9 | 2019 | 42 | |
| 10 | 2022 | 23 | |
| 11 | 2024 | 23 | |
| 12 | 2023 | 10 | |
| 13 | 2025 | 6 | |
| 14 | 2018 | 5 | |
| 15 | 2025 | 3 | |
| 16 | 2022 | 2 | |
| 17 | 2019 | 1 | |
| 18 | 2017 | 0 | |
| 19 | 2024 | 0 |
About Jonas Andreas Schmid
Jonas Andreas Schmid is a scholar working on Oncology, Molecular Biology, Hematology, Cancer Research and Public Administration, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (9 papers), PARP inhibition in cancer therapy (5 papers), CRISPR and Genetic Engineering (4 papers), Luminescence and Fluorescent Materials (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), interferon and immune responses (2 papers), Cancer-related Molecular Pathways (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Oncology (749 citations), Molecular Biology (1.3k citations), Immunology (231 citations), Cancer Research (152 citations) and Cell Biology (110 citations). Jonas Andreas Schmid has collaborated with scholars based in Switzerland, United States and Netherlands. Frequent co-authors include Massimo Lopes, Matteo Berti, Ralph Zellweger, Raquel Herrador, Alessandro Vindigni, Damian Dalcher, Karun Mutreja, Jana Krietsch, Katharina Zwicky and Lorenza Penengo. Their work appears in journals such as Molecular Cell, Cancer Cell, Nature Communications, The Journal of Cell Biology and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.